Plasma neurofilament light in progressive multiple sclerosis
- PMID: 31618445
- DOI: 10.1111/ane.13184
Plasma neurofilament light in progressive multiple sclerosis
Comment on
-
Plasma neurofilaments correlate with disability in progressive multiple sclerosis patients.Acta Neurol Scand. 2020 Jan;141(1):16-21. doi: 10.1111/ane.13152. Epub 2019 Aug 26. Acta Neurol Scand. 2020. PMID: 31350854
References
REFERENCES
-
- Karlsson JE, Rosengren LE, Haglid KG. A rapid HPLC method to separate the triplet proteins of neurofilament. J Neurochem. 1987;49(5):1375-1378.
-
- Karlsson JE, Rosengren LE, Haglid KG. Polyclonal antisera to the individual neurofilament triplet proteins: a characterization using ELISA and immunoblotting. J Neurochem. 1989;53(3):759-765.
-
- Rosengren LE, Karlsson JE, Karlsson JO, Persson LI, Wikkelso C. Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J Neurochem. 1996;67(5):2013-2018.
-
- Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H. Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry. 2019;90(8):870-881.
-
- Bridel C, van Wieringen WN, Zetterberg H, et al. Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis. JAMA Neurol. 2019. https://doi.org/10.1001/jamaneurol.2019.1534. [Epub ahead of print].
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
